Insurance Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Insurance Press Releases.

Press releases published on September 22, 2026

Sep. 22, 2026

365 Data Centers and Megaport Expand Partnership into Nine Additional Markets

Indeterminate GlobeNewswire

Sep. 22, 2026

Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD

Indeterminate GlobeNewswire

Sep. 22, 2026

Financial Services Virtual Investor Conference Agenda Announced

Indeterminate GlobeNewswire

Sep. 22, 2026

Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker

Indeterminate GlobeNewswire

Sep. 22, 2026

SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes

Indeterminate GlobeNewswire

Sep. 22, 2026

Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015

Indeterminate GlobeNewswire

Sep. 22, 2026

Marchex Expands Investor Relations Program, Engages PondelWilkinson to Broaden Investor Outreach

Indeterminate GlobeNewswire

Sep. 22, 2026

Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome

Indeterminate GlobeNewswire

Sep. 22, 2026

Grayscale Investments Introduces Grayscale AI Compute ETF (Ticker: GCPU), Targeting the Infrastructure Powering AI's Growth

Indeterminate GlobeNewswire

Sep. 22, 2026

Capstone Asset Management Inc. Announces Third Quarter 2026 Cash Distributions for ETF Series of Capstone Funds

Indeterminate GlobeNewswire

Sep. 22, 2026

Superstar Platforms Announces Agreement to Acquire TitlePal, Inc.

Indeterminate GlobeNewswire

Sep. 22, 2026

Compass Therapeutics Provides Regulatory Update on Tovecimig in Biliary Tract Cancer Following FDA Feedback

Indeterminate GlobeNewswire

Sep. 22, 2026

Vistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Indeterminate GlobeNewswire

Sep. 22, 2026

Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria

Indeterminate GlobeNewswire

Sep. 22, 2026

Chipmakers Now Ship Protein-Folding AI as Plug-and-Play Microservices

Indeterminate GlobeNewswire

Sep. 22, 2026

Abercrombie & Fitch Expands Partnership with Dallas Cowboys and Dallas Cowboys Cheerleaders

Indeterminate GlobeNewswire

Sep. 22, 2026

Zeo Energy Enters Cooperation Agreement with Ewyze to Develop Integrated Off-Grid Power and Data-Center Infrastructure

Indeterminate GlobeNewswire

Sep. 22, 2026

Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium

Indeterminate GlobeNewswire

Sep. 22, 2026

VistaShares Introduces the Shield Family of ETFs, Providing The Better Buffer Advisors and Investors Have Been Seeking

Indeterminate GlobeNewswire

Sep. 22, 2026

REE, Critical Metals Demand Surging as Western Nations Race to Secure Alternatives

Indeterminate GlobeNewswire